AI-Powered News AnalysisCompare coverage across the political spectrum
Back to Dashboard
GSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial Reuters

July 10, 2026 at 01:46 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

All Coverage

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNUXlQTnc4VFk4Uk1DZ194V2xNcEhDVkF4aDNmRXhtbnBaZVJ2TFpjSFRSUmF2Skh6R3FVZGNpWUVUckQxdDB3a1lOdVlPNk45REYzRzBLdk5sSnM3X3owa0EtN0k3VWVTODRkQ3JfVzFDOHNhNm5DWXF3Vm5rX0lJNVN5YVV6a1dLX3JNVFprZnZTMDJIOGlJV0hab21VLWxycDR6ZFNFV1E2cHR1REtkckVVd0szMFNMY25fN0w0YnpiV0NpdGdBbW1TSE90V0xxYko1eTZ4TQ?oc=5" target="_blank">GSK, Hansoh's targeted cancer drug hits main survival goal in China trial</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%